Modern cancer care utilizes cabozantinib tablets to block the tyrosine kinases responsible for tumor growth and metastatic progression. By inhibiting MET and AXL—pathways often associated with resistance to standard VEGF therapy—the drug offers a refined mechanism for disease control. In the UK, cabozantinib tablets provide a specialized treatment path for radioiodine-refractory diffe... https://www.oddwayinternational.com/cabozantinib-tablet/